世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Multiple Drug Resistance Bacterial Infection Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4533 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、多剤耐性細菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリティカル、ミディアム、ハイ）、用途別市場規模（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環状リポペプチド、グリコリポペプチド）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・多剤耐性細菌感染症治療の市場動向 ・企業の競争状況、市場シェア ・多剤耐性細菌感染症治療の種類別市場規模と予測2016-2027（クリティカル、ミディアム、ハイ） ・多剤耐性細菌感染症治療の用途別市場規模と予測2016-2027（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環状リポペプチド、グリコリポペプチド） ・多剤耐性細菌感染症治療の北米市場規模2016-2027（アメリカ、カナダ） ・多剤耐性細菌感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・多剤耐性細菌感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・多剤耐性細菌感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・多剤耐性細菌感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories, Inc.、Actelion Pharmaceuticals Ltd.、Albany Molecular Research, Inc.、Allergan plc.、AstraZeneca、Bayer AG、Biocon、Daiichi Sankyo Company、GlaxoSmithKline plc.、Macrolide Pharmaceuticals, Inc.、Merck & Co, Inc.、Pfizer, Inc.、Sanofi、Teva Pharmaceuticals Industries Ltd.、Wockhardt、Zavante Therapeutics, Inc.） ・結論

Multidrug-resistant bacteria (MDROS), also known as multidrug-resistant microorganisms, are the result of bacterial variation and excessive use of antimicrobial agents.

Market Analysis and Insights: Global Multiple Drug Resistance Bacterial Infection Treatment Market
The global Multiple Drug Resistance Bacterial Infection Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Multiple Drug Resistance Bacterial Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Multiple Drug Resistance Bacterial Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Multiple Drug Resistance Bacterial Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Multiple Drug Resistance Bacterial Infection Treatment market.

Global Multiple Drug Resistance Bacterial Infection Treatment Scope and Market Size
Multiple Drug Resistance Bacterial Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Drug Resistance Bacterial Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Critical
Medium
High

Segment by Application
Cephalosporin
Beta Lactam
Beta Lactamase Inhibitors
Oxazolidinone
Cyclic Lipopeptide
Glycolipopeptides

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories, Inc.
Actelion Pharmaceuticals Ltd.
Albany Molecular Research, Inc.
Allergan plc.
AstraZeneca
Bayer AG
Biocon
Daiichi Sankyo Company
GlaxoSmithKline plc.
Macrolide Pharmaceuticals, Inc.
Merck & Co, Inc.
Pfizer, Inc.
Sanofi
Teva Pharmaceuticals Industries Ltd.
Wockhardt
Zavante Therapeutics, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiple Drug Resistance Bacterial Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Critical
1.2.3 Medium
1.2.4 High
1.3 Market by Application
1.3.1 Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cephalosporin
1.3.3 Beta Lactam
1.3.4 Beta Lactamase Inhibitors
1.3.5 Oxazolidinone
1.3.6 Cyclic Lipopeptide
1.3.7 Glycolipopeptides
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Multiple Drug Resistance Bacterial Infection Treatment Market Perspective (2016-2027)
2.2 Multiple Drug Resistance Bacterial Infection Treatment Growth Trends by Regions
2.2.1 Multiple Drug Resistance Bacterial Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Multiple Drug Resistance Bacterial Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Multiple Drug Resistance Bacterial Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Multiple Drug Resistance Bacterial Infection Treatment Industry Dynamic
2.3.1 Multiple Drug Resistance Bacterial Infection Treatment Market Trends
2.3.2 Multiple Drug Resistance Bacterial Infection Treatment Market Drivers
2.3.3 Multiple Drug Resistance Bacterial Infection Treatment Market Challenges
2.3.4 Multiple Drug Resistance Bacterial Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Multiple Drug Resistance Bacterial Infection Treatment Players by Revenue
3.1.1 Global Top Multiple Drug Resistance Bacterial Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global Multiple Drug Resistance Bacterial Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Multiple Drug Resistance Bacterial Infection Treatment Revenue
3.4 Global Multiple Drug Resistance Bacterial Infection Treatment Market Concentration Ratio
3.4.1 Global Multiple Drug Resistance Bacterial Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiple Drug Resistance Bacterial Infection Treatment Revenue in 2020
3.5 Multiple Drug Resistance Bacterial Infection Treatment Key Players Head office and Area Served
3.6 Key Players Multiple Drug Resistance Bacterial Infection Treatment Product Solution and Service
3.7 Date of Enter into Multiple Drug Resistance Bacterial Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Multiple Drug Resistance Bacterial Infection Treatment Breakdown Data by Type
4.1 Global Multiple Drug Resistance Bacterial Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global Multiple Drug Resistance Bacterial Infection Treatment Forecasted Market Size by Type (2022-2027)

5 Multiple Drug Resistance Bacterial Infection Treatment Breakdown Data by Application
5.1 Global Multiple Drug Resistance Bacterial Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global Multiple Drug Resistance Bacterial Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size (2016-2027)
6.2 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type
6.2.1 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2027)
6.3 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application
6.3.1 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2027)
6.4 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country
6.4.1 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size (2016-2027)
7.2 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type
7.2.1 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2027)
7.3 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application
7.3.1 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2027)
7.4 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country
7.4.1 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type
8.2.1 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application
8.3.1 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Region
8.4.1 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size (2016-2027)
9.2 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type
9.2.1 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application
9.3.1 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country
9.4.1 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type
10.2.1 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application
10.3.1 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country
10.4.1 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Details
11.1.2 Abbott Laboratories, Inc. Business Overview
11.1.3 Abbott Laboratories, Inc. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.1.4 Abbott Laboratories, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.1.5 Abbott Laboratories, Inc. Recent Development
11.2 Actelion Pharmaceuticals Ltd.
11.2.1 Actelion Pharmaceuticals Ltd. Company Details
11.2.2 Actelion Pharmaceuticals Ltd. Business Overview
11.2.3 Actelion Pharmaceuticals Ltd. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.2.4 Actelion Pharmaceuticals Ltd. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.2.5 Actelion Pharmaceuticals Ltd. Recent Development
11.3 Albany Molecular Research, Inc.
11.3.1 Albany Molecular Research, Inc. Company Details
11.3.2 Albany Molecular Research, Inc. Business Overview
11.3.3 Albany Molecular Research, Inc. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.3.4 Albany Molecular Research, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.3.5 Albany Molecular Research, Inc. Recent Development
11.4 Allergan plc.
11.4.1 Allergan plc. Company Details
11.4.2 Allergan plc. Business Overview
11.4.3 Allergan plc. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.4.4 Allergan plc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.4.5 Allergan plc. Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.5.4 AstraZeneca Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.6.4 Bayer AG Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.6.5 Bayer AG Recent Development
11.7 Biocon
11.7.1 Biocon Company Details
11.7.2 Biocon Business Overview
11.7.3 Biocon Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.7.4 Biocon Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.7.5 Biocon Recent Development
11.8 Daiichi Sankyo Company
11.8.1 Daiichi Sankyo Company Company Details
11.8.2 Daiichi Sankyo Company Business Overview
11.8.3 Daiichi Sankyo Company Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.8.4 Daiichi Sankyo Company Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.8.5 Daiichi Sankyo Company Recent Development
11.9 GlaxoSmithKline plc.
11.9.1 GlaxoSmithKline plc. Company Details
11.9.2 GlaxoSmithKline plc. Business Overview
11.9.3 GlaxoSmithKline plc. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.9.4 GlaxoSmithKline plc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.9.5 GlaxoSmithKline plc. Recent Development
11.10 Macrolide Pharmaceuticals, Inc.
11.10.1 Macrolide Pharmaceuticals, Inc. Company Details
11.10.2 Macrolide Pharmaceuticals, Inc. Business Overview
11.10.3 Macrolide Pharmaceuticals, Inc. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.10.4 Macrolide Pharmaceuticals, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.10.5 Macrolide Pharmaceuticals, Inc. Recent Development
11.11 Merck & Co, Inc.
11.11.1 Merck & Co, Inc. Company Details
11.11.2 Merck & Co, Inc. Business Overview
11.11.3 Merck & Co, Inc. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.11.4 Merck & Co, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.11.5 Merck & Co, Inc. Recent Development
11.12 Pfizer, Inc.
11.12.1 Pfizer, Inc. Company Details
11.12.2 Pfizer, Inc. Business Overview
11.12.3 Pfizer, Inc. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.12.4 Pfizer, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.12.5 Pfizer, Inc. Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.13.4 Sanofi Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.13.5 Sanofi Recent Development
11.14 Teva Pharmaceuticals Industries Ltd.
11.14.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.14.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.14.3 Teva Pharmaceuticals Industries Ltd. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.14.4 Teva Pharmaceuticals Industries Ltd. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.14.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.15 Wockhardt
11.15.1 Wockhardt Company Details
11.15.2 Wockhardt Business Overview
11.15.3 Wockhardt Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.15.4 Wockhardt Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.15.5 Wockhardt Recent Development
11.16 Zavante Therapeutics, Inc.
11.16.1 Zavante Therapeutics, Inc. Company Details
11.16.2 Zavante Therapeutics, Inc. Business Overview
11.16.3 Zavante Therapeutics, Inc. Multiple Drug Resistance Bacterial Infection Treatment Introduction
11.16.4 Zavante Therapeutics, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
11.16.5 Zavante Therapeutics, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Critical
Table 3. Key Players of Medium
Table 4. Key Players of High
Table 5. Global Multiple Drug Resistance Bacterial Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Multiple Drug Resistance Bacterial Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Multiple Drug Resistance Bacterial Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Regions (2016-2021)
Table 9. Global Multiple Drug Resistance Bacterial Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Regions (2022-2027)
Table 11. Multiple Drug Resistance Bacterial Infection Treatment Market Trends
Table 12. Multiple Drug Resistance Bacterial Infection Treatment Market Drivers
Table 13. Multiple Drug Resistance Bacterial Infection Treatment Market Challenges
Table 14. Multiple Drug Resistance Bacterial Infection Treatment Market Restraints
Table 15. Global Multiple Drug Resistance Bacterial Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Players (2016-2021)
Table 17. Global Top Multiple Drug Resistance Bacterial Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Drug Resistance Bacterial Infection Treatment as of 2020)
Table 18. Ranking of Global Top Multiple Drug Resistance Bacterial Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Multiple Drug Resistance Bacterial Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Multiple Drug Resistance Bacterial Infection Treatment Product Solution and Service
Table 22. Date of Enter into Multiple Drug Resistance Bacterial Infection Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Multiple Drug Resistance Bacterial Infection Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Multiple Drug Resistance Bacterial Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Multiple Drug Resistance Bacterial Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Multiple Drug Resistance Bacterial Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Multiple Drug Resistance Bacterial Infection Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Multiple Drug Resistance Bacterial Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Multiple Drug Resistance Bacterial Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Laboratories, Inc. Company Details
Table 63. Abbott Laboratories, Inc. Business Overview
Table 64. Abbott Laboratories, Inc. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 65. Abbott Laboratories, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 66. Abbott Laboratories, Inc. Recent Development
Table 67. Actelion Pharmaceuticals Ltd. Company Details
Table 68. Actelion Pharmaceuticals Ltd. Business Overview
Table 69. Actelion Pharmaceuticals Ltd. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 70. Actelion Pharmaceuticals Ltd. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 71. Actelion Pharmaceuticals Ltd. Recent Development
Table 72. Albany Molecular Research, Inc. Company Details
Table 73. Albany Molecular Research, Inc. Business Overview
Table 74. Albany Molecular Research, Inc. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 75. Albany Molecular Research, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 76. Albany Molecular Research, Inc. Recent Development
Table 77. Allergan plc. Company Details
Table 78. Allergan plc. Business Overview
Table 79. Allergan plc. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 80. Allergan plc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 81. Allergan plc. Recent Development
Table 82. AstraZeneca Company Details
Table 83. AstraZeneca Business Overview
Table 84. AstraZeneca Multiple Drug Resistance Bacterial Infection Treatment Product
Table 85. AstraZeneca Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 86. AstraZeneca Recent Development
Table 87. Bayer AG Company Details
Table 88. Bayer AG Business Overview
Table 89. Bayer AG Multiple Drug Resistance Bacterial Infection Treatment Product
Table 90. Bayer AG Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 91. Bayer AG Recent Development
Table 92. Biocon Company Details
Table 93. Biocon Business Overview
Table 94. Biocon Multiple Drug Resistance Bacterial Infection Treatment Product
Table 95. Biocon Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 96. Biocon Recent Development
Table 97. Daiichi Sankyo Company Company Details
Table 98. Daiichi Sankyo Company Business Overview
Table 99. Daiichi Sankyo Company Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 100. Daiichi Sankyo Company Recent Development
Table 101. GlaxoSmithKline plc. Company Details
Table 102. GlaxoSmithKline plc. Business Overview
Table 103. GlaxoSmithKline plc. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 104. GlaxoSmithKline plc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 105. GlaxoSmithKline plc. Recent Development
Table 106. Macrolide Pharmaceuticals, Inc. Company Details
Table 107. Macrolide Pharmaceuticals, Inc. Business Overview
Table 108. Macrolide Pharmaceuticals, Inc. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 109. Macrolide Pharmaceuticals, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 110. Macrolide Pharmaceuticals, Inc. Recent Development
Table 111. Merck & Co, Inc. Company Details
Table 112. Merck & Co, Inc. Business Overview
Table 113. Merck & Co, Inc. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 114. Merck & Co, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 115. Merck & Co, Inc. Recent Development
Table 116. Pfizer, Inc. Company Details
Table 117. Pfizer, Inc. Business Overview
Table 118. Pfizer, Inc. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 119. Pfizer, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 120. Pfizer, Inc. Recent Development
Table 121. Sanofi Company Details
Table 122. Sanofi Business Overview
Table 123. Sanofi Multiple Drug Resistance Bacterial Infection Treatment Product
Table 124. Sanofi Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 125. Sanofi Recent Development
Table 126. Teva Pharmaceuticals Industries Ltd. Company Details
Table 127. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 128. Teva Pharmaceuticals Industries Ltd. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 129. Teva Pharmaceuticals Industries Ltd. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 130. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 131. Wockhardt Company Details
Table 132. Wockhardt Business Overview
Table 133. Wockhardt Multiple Drug Resistance Bacterial Infection Treatment Product
Table 134. Wockhardt Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 135. Wockhardt Recent Development
Table 136. Zavante Therapeutics, Inc. Company Details
Table 137. Zavante Therapeutics, Inc. Business Overview
Table 138. Zavante Therapeutics, Inc. Multiple Drug Resistance Bacterial Infection Treatment Product
Table 139. Zavante Therapeutics, Inc. Revenue in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021) & (US$ Million)
Table 140. Zavante Therapeutics, Inc. Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. Critical Features
Figure 3. Medium Features
Figure 4. High Features
Figure 5. Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Application: 2020 VS 2027
Figure 6. Cephalosporin Case Studies
Figure 7. Beta Lactam Case Studies
Figure 8. Beta Lactamase Inhibitors Case Studies
Figure 9. Oxazolidinone Case Studies
Figure 10. Cyclic Lipopeptide Case Studies
Figure 11. Glycolipopeptides Case Studies
Figure 12. Multiple Drug Resistance Bacterial Infection Treatment Report Years Considered
Figure 13. Global Multiple Drug Resistance Bacterial Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Multiple Drug Resistance Bacterial Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Regions (2022-2027)
Figure 17. Global Multiple Drug Resistance Bacterial Infection Treatment Market Share by Players in 2020
Figure 18. Global Top Multiple Drug Resistance Bacterial Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Drug Resistance Bacterial Infection Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Multiple Drug Resistance Bacterial Infection Treatment Revenue in 2020
Figure 20. Global Multiple Drug Resistance Bacterial Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Multiple Drug Resistance Bacterial Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Multiple Drug Resistance Bacterial Infection Treatment Market Share by Type (2016-2027)
Figure 24. North America Multiple Drug Resistance Bacterial Infection Treatment Market Share by Application (2016-2027)
Figure 25. North America Multiple Drug Resistance Bacterial Infection Treatment Market Share by Country (2016-2027)
Figure 26. United States Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Share by Type (2016-2027)
Figure 30. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Share by Application (2016-2027)
Figure 31. Europe Multiple Drug Resistance Bacterial Infection Treatment Market Share by Country (2016-2027)
Figure 32. Germany Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Multiple Drug Resistance Bacterial Infection Treatment Market Share by Region (2016-2027)
Figure 42. China Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Multiple Drug Resistance Bacterial Infection Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Multiple Drug Resistance Bacterial Infection Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Multiple Drug Resistance Bacterial Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Laboratories, Inc. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 62. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 63. Albany Molecular Research, Inc. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 64. Allergan plc. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 66. Bayer AG Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 67. Biocon Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 68. Daiichi Sankyo Company Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 69. GlaxoSmithKline plc. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 70. Macrolide Pharmaceuticals, Inc. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 71. Merck & Co, Inc. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 72. Pfizer, Inc. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 73. Sanofi Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 74. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 75. Wockhardt Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 76. Zavante Therapeutics, Inc. Revenue Growth Rate in Multiple Drug Resistance Bacterial Infection Treatment Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---